Recently, a meta-analysis of genome-wide association showed an inverse association between ATP6AP2 and multiple sclerosis, Alzheimer’s disease and Parkinson’s disease [44]. Here, ATP6AP2 is linked to early-onset autosomal dominant Alzheimer disease.